Daiwa Securities Group Inc. boosted its holdings in shares of Zoetis Inc (NYSE:ZTS) by 4.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,773 shares of the company’s stock after purchasing an additional 853 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Zoetis were worth $1,719,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the business. Banque Pictet & Cie SA lifted its position in shares of Zoetis by 5,516.1% in the second quarter. Banque Pictet & Cie SA now owns 1,679,617 shares of the company’s stock valued at $143,087,000 after acquiring an additional 1,649,710 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Zoetis by 22.3% in the second quarter. Janus Henderson Group PLC now owns 5,410,040 shares of the company’s stock valued at $460,890,000 after acquiring an additional 985,586 shares in the last quarter. Bank of Montreal Can lifted its position in shares of Zoetis by 190.7% in the second quarter. Bank of Montreal Can now owns 1,327,357 shares of the company’s stock valued at $113,078,000 after acquiring an additional 870,807 shares in the last quarter. New York State Teachers Retirement System lifted its position in shares of Zoetis by 97.7% in the second quarter. New York State Teachers Retirement System now owns 1,543,772 shares of the company’s stock valued at $130,202,000 after acquiring an additional 762,828 shares in the last quarter. Finally, Marshall Wace LLP lifted its position in shares of Zoetis by 62.6% in the second quarter. Marshall Wace LLP now owns 1,823,176 shares of the company’s stock valued at $155,316,000 after acquiring an additional 701,801 shares in the last quarter. Institutional investors own 89.68% of the company’s stock.
In related news, insider Roxanne Lagano sold 2,000 shares of the stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $92.03, for a total value of $184,060.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Juan Ramon Alaix sold 135,000 shares of the stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $91.55, for a total value of $12,359,250.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 350,507 shares of company stock valued at $32,579,830. Insiders own 0.35% of the company’s stock.
NYSE:ZTS opened at $95.27 on Friday. Zoetis Inc has a one year low of $68.56 and a one year high of $96.57. The company has a quick ratio of 2.63, a current ratio of 4.06 and a debt-to-equity ratio of 3.04. The company has a market capitalization of $45.73 billion, a P/E ratio of 39.70, a P/E/G ratio of 1.87 and a beta of 0.97.
Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, November 1st. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.77 by $0.06. Zoetis had a return on equity of 75.51% and a net margin of 20.35%. The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.46 billion. During the same quarter last year, the firm earned $0.65 earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. As a group, equities research analysts anticipate that Zoetis Inc will post 3.11 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, December 3rd. Investors of record on Tuesday, November 20th will be issued a $0.126 dividend. The ex-dividend date is Monday, November 19th. This represents a $0.50 annualized dividend and a dividend yield of 0.53%. Zoetis’s dividend payout ratio is presently 20.83%.
Several research firms have recently weighed in on ZTS. BMO Capital Markets restated a “hold” rating and issued a $82.00 target price on shares of Zoetis in a research report on Thursday, August 2nd. Zacks Investment Research upgraded Zoetis from a “hold” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, October 17th. Morgan Stanley set a $100.00 target price on Zoetis and gave the company a “hold” rating in a research report on Friday, November 2nd. Stifel Nicolaus downgraded Zoetis from a “buy” rating to a “hold” rating and set a $95.00 target price on the stock. in a research report on Tuesday, August 21st. They noted that the move was a valuation call. Finally, Argus raised their target price on Zoetis from $90.00 to $103.00 and gave the company a “buy” rating in a research report on Tuesday, August 14th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Zoetis currently has an average rating of “Buy” and a consensus target price of $93.19.
TRADEMARK VIOLATION WARNING: “Zoetis Inc (ZTS) Holdings Boosted by Daiwa Securities Group Inc.” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/11/11/zoetis-inc-zts-holdings-boosted-by-daiwa-securities-group-inc-2.html.
Zoetis, Inc discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The firm provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals.
Featured Article: Moving Average (MA)
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.